51. Trial of Universal Gloving with Emollient-Impregnated Gloves to Promote Skin Health and Prevent the Transmission of Multidrug-Resistant Organisms in a Surgical Intensive Care Unit
- Author
-
Cheryl Haner, Kakotan Sanogo, Valentina Kazlova, Gonzalo Bearman, Adriana E. Rosato, Therese M. Duane, Kara Elam, and Michael B. Edmond
- Subjects
Methicillin-Resistant Staphylococcus aureus ,Microbiology (medical) ,medicine.medical_specialty ,Critical Care ,Epidemiology ,Health Personnel ,media_common.quotation_subject ,medicine.disease_cause ,law.invention ,law ,Hygiene ,Drug Resistance, Multiple, Bacterial ,Health care ,Humans ,Medicine ,Infection control ,Gloves, Surgical ,Intensive care medicine ,Gram-Positive Bacterial Infections ,Skin ,media_common ,Cross Infection ,Infection Control ,Emollients ,business.industry ,Ventilator-associated pneumonia ,Vancomycin Resistance ,Clostridium difficile ,medicine.disease ,Intensive care unit ,Methicillin-resistant Staphylococcus aureus ,Intensive Care Units ,Infectious Diseases ,Vancomycin ,Guideline Adherence ,Gloves, Protective ,business ,Enterococcus ,Hand Disinfection ,medicine.drug - Abstract
Objective.To compare the efficacy of universal gloving with emollient-impregnated gloves with standard contact precautions for the control of multidrug-resistant organisms (MDROs) and to measure the effect on healthcare workers' (HCWs') hand skin health.Design.Prospective before-after trial.Setting.An 18-bed surgical intensive care unit.Methods.During phase 1 (September 2007 through March 2008) standard contact precautions were used. During phase 2 (March 2008 through September 2008) universal gloving with emollient-impregnated gloves was used, and no contact precautions. Patients were screened for vancomycin-resistantEnterococcus(VRE) and methicillin-resistantStaphylococcus aureus(MRSA). HCW hand hygiene compliance and hand skin health and microbial contamination were assessed. The incidences of device-associated infection andClostridium difficileinfection (CDI) were determined.Results.The rate of compliance with contact precautions (phase 1) was 67%, and the rate of compliance with universal gloving (phase 2) was 78% (P= .01). Hand hygiene compliance was higher during phase 2 than during phase 1 (before patient care, 40% vs 35% of encounters;P= .001; after patient care, 63% vs 51% of encounters;P< .001). No difference was observed in MDRO acquisition. During phases 1 and 2, incidences of device-related infections, in number of infections per 1,000 device-days, were, respectively, 3.7 and 2.6 for bloodstream infection (P= .10), 8.9 and 7.8 for urinary tract infection (P= .10), and 1.0 and 1.1 for ventilator-associated pneumonia (P= .09). The CDI incidence in phase 1 and in phase 2 was, respectively, 2.0 and 1.4 cases per 1,000 patient-days (P= .53). During phase 1, 29% of HCW hand cultures were MRSA positive, compared with 13% during phase 2 (P= .17); during phase 1, 2% of hand cultures were VRE positive, compared with 0 during phase 2 (P= .16). Hand skin health improved during phase 2.Conclusions.Compared with contact precautions, universal gloving with emollient-impregnated gloves was associated with improved hand hygiene compliance and skin health. No statistically significant change in the rates of device-associated infection, CDI, or patient MDRO acquisition was observed. Universal gloving may be an alternative to contact precautions.
- Published
- 2010
- Full Text
- View/download PDF